These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23965990)

  • 1. Effect of charged residues in the N-domain of Sup35 protein on prion [PSI+] stability and propagation.
    Bondarev SA; Shchepachev VV; Kajava AV; Zhouravleva GA
    J Biol Chem; 2013 Oct; 288(40):28503-13. PubMed ID: 23965990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modification of [PSI+] prion properties by the combination of amino acid changes within Sup35 protein N-domain].
    Bondarev SA; Shirokolobova ED; Trubitsyna NP; Zhuravleva GA
    Mol Biol (Mosk); 2014; 48(2):314-21. PubMed ID: 25850301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PSI+] maintenance is dependent on the composition, not primary sequence, of the oligopeptide repeat domain.
    Toombs JA; Liss NM; Cobble KR; Ben-Musa Z; Ross ED
    PLoS One; 2011; 6(7):e21953. PubMed ID: 21760933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism and application of molecular self-assembly in Sup35 prion domain of Saccharomyces cerevisiae].
    Yin W; He J; Yu Z; Wang J
    Sheng Wu Gong Cheng Xue Bao; 2011 Oct; 27(10):1401-7. PubMed ID: 22260056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rnq1 protein protects [PSI^(+)] prion from effect of the PNM mutation].
    Bondarev SA; Likholetova DV; Belousov MV; Zhouravleva GA
    Mol Biol (Mosk); 2017; 51(2):367-371. PubMed ID: 28537243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locating folds of the in-register parallel β-sheet of the Sup35p prion domain infectious amyloid.
    Gorkovskiy A; Thurber KR; Tycko R; Wickner RB
    Proc Natl Acad Sci U S A; 2014 Oct; 111(43):E4615-22. PubMed ID: 25313080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth phase-dependent changes in the size and infectivity of SDS-resistant Sup35p assemblies associated with the [PSI
    Wang K; Melki R; Kabani M
    Mol Microbiol; 2019 Sep; 112(3):932-943. PubMed ID: 31206803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutation within the C-terminal domain of Sup35p that affects [PSI+] prion propagation.
    Kabani M; Cosnier B; Bousset L; Rousset JP; Melki R; Fabret C
    Mol Microbiol; 2011 Aug; 81(3):640-58. PubMed ID: 21631606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for transmission barrier and interference between closely related prion proteins in yeast.
    Afanasieva EG; Kushnirov VV; Tuite MF; Ter-Avanesyan MD
    J Biol Chem; 2011 May; 286(18):15773-80. PubMed ID: 21454674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The [PSI+] prion exists as a dynamic cloud of variants.
    Bateman DA; Wickner RB
    PLoS Genet; 2013; 9(1):e1003257. PubMed ID: 23382698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PNM2 mutation in the prion protein domain of SUP35 has distinct effects on different variants of the [PSI+] prion in yeast.
    Derkatch IL; Bradley ME; Zhou P; Liebman SW
    Curr Genet; 1999 Mar; 35(2):59-67. PubMed ID: 10079323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the N-terminal oligopeptide repeats of the yeast Sup35 prion protein in propagation and transmission of prion variants.
    Shkundina IS; Kushnirov VV; Tuite MF; Ter-Avanesyan MD
    Genetics; 2006 Feb; 172(2):827-35. PubMed ID: 16272413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NatA acetyltransferase couples Sup35 prion complexes to the [PSI+] phenotype.
    Pezza JA; Langseth SX; Raupp Yamamoto R; Doris SM; Ulin SP; Salomon AR; Serio TR
    Mol Biol Cell; 2009 Feb; 20(3):1068-80. PubMed ID: 19073888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Yarrowia lipolytica orthologs of Sup35p assemble into thioflavin T-negative amyloid fibrils.
    Kabani M; Melki R
    Biochem Biophys Res Commun; 2020 Aug; 529(3):533-539. PubMed ID: 32736670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Sup35 domains required for maintenance of weak, strong or undifferentiated yeast [PSI+] prions.
    Bradley ME; Liebman SW
    Mol Microbiol; 2004 Mar; 51(6):1649-59. PubMed ID: 15009892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of inhibition of Psi+ prion determinant propagation by a mutation of the N-terminus of the yeast Sup35 protein.
    Kochneva-Pervukhova NV; Paushkin SV; Kushnirov VV; Cox BS; Tuite MF; Ter-Avanesyan MD
    EMBO J; 1998 Oct; 17(19):5805-10. PubMed ID: 9755180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yeast Sup35 Prion Structure: Two Types, Four Parts, Many Variants.
    Dergalev AA; Alexandrov AI; Ivannikov RI; Ter-Avanesyan MD; Kushnirov VV
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor.
    Paushkin SV; Kushnirov VV; Smirnov VN; Ter-Avanesyan MD
    EMBO J; 1996 Jun; 15(12):3127-34. PubMed ID: 8670813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new perspective on Hsp104-mediated propagation and curing of the yeast prion [PSI (+) ].
    Helsen CW; Glover JR
    Prion; 2012 Jul; 6(3):234-9. PubMed ID: 22561166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsense Mutations in the Yeast
    Trubitsina NP; Zemlyanko OM; Bondarev SA; Zhouravleva GA
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.